(Ivanhoe Newswire) — Researchers found people with lung cancer were significantly more likely to have several high-risk forms of human papillomavirus (HPV) antibodies compared to those who didn’t have lung cancer.
Devasena Anantharaman, Ph.D., postdoctoral fellow in the Genetic Epidemiology Group at the International Agency for Research on Cancer (IARC) in Lyon, France, and colleagues used serological tests to determine the presence of several high-risk and low-risk types of HPV in 1,633 lung cancer cases and 2,729 matched controls from six central European countries. Among the lung cancer-free controls, researchers found a low prevalence of antibodies to all types of HPV tested. In lung cancer patients, antibodies to proteins in eight types of high-risk HPV were significantly increased.
Leave a Reply